Stocks/OVID

Create a free account to see ACCE Scores

Sign up for free to unlock scores, score breakdowns, and stock analysis.

OVID

↓ PDF (Pro)
Ovid Therapeutics Inc. Common Stock
HealthcareBiotechnologyUnited StatesNASDAQ
$2.89
-1.37%today
MKT CAP
$482M
-1.4% · 1Y
Earnings History
-7.7%
+59.3%
-14.9%
+161.2%
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Analyst Targets
Current price
$2.89
Low
$4.00
Analyst Mean
$5.25
High
$7.00
9 analystsNone
Full Financials
Trailing P/E-
Forward P/E-
EV/EBITDA-7.4x
Price/Sales-
Dividend Yield-
Revenue Growth YoY+844.7%
Earnings Growth YoY-
Revenue Growth QoQ+443.9%
5y Revenue CAGR+69.0%
5y Earnings CAGR-
Gross Margin100.0%
Operating Margin-1712.1%
Net Margin-240.1%
ROE-17.5%
Debt / Equity10.27x
Free Cash Flow$-25,643,376
Insider Ownership7.5%
Institutional Ownership35.7%
Short % of Float4.31%
Days to Cover1.3d
1 Week+6.2%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
FilerRoleTypeSharesPriceValueDate
PAPADOPOULOS STELIOS BDirectorStock17,578$2.56$0.04M2026-04-07
FRIEDMAN BARTDirectorStock8,789$2.56$0.02M2026-04-07
FITZGERALD KEVIN JOSEPHDirectorStock17,578$2.56$0.04M2026-04-07
LEVIN JEREMY MOfficer and DirectorConversion47,333$1.40$0.07M2026-03-23
RONA JEFFREY AOfficerStock68,125$0.00$0.00M2026-02-26
Top Holders
HolderType% HeldValueΔ SharesAs of
RA Capital Management, L.P.institution6.19%$0.03B+100.00%2025-12-31
Affinity Asset Advisors, Llcinstitution4.13%$0.02B+169.81%2025-12-31
Eventide Asset Management LLCinstitution2.48%$0.01B+100.00%2025-12-31
Adar1 Capital Management, LLC institution2.48%$0.01B+33256.69%2025-12-31
Federated Hermes, Inc.institution2.06%$0.01B+100.00%2025-12-31
Federated Hermes Equity Funds-Federated Hermes Kaufmann Small Cap Fundfund2.06%$0.01B+100.00%2026-01-31
Point72 Asset Management, L.P.institution2.05%$0.01B+100.00%2025-12-31
Adage Capital Partners GP L.L.C.institution2.02%$0.01B+158.67%2025-12-31
Vanguard Group Incinstitution1.78%$0.01B+8.91%2025-12-31
Saturn V Capital Management LPinstitution1.44%$0.01B+100.00%2025-12-31
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fundfund1.16%$0.01B+12.81%2025-12-31
Ally Bridge Group (NY) LLCinstitution1.03%$0.00B+100.00%2025-12-31
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fundfund0.36%$0.00B+0.00%2025-12-31
Fidelity Concord Street Trust-Fidelity Extended Market Index Fundfund0.19%$0.00B-0.36%2026-02-28
Fidelity Concord Street Trust-Fidelity Total Market Index Fundfund0.12%$0.00B+80.06%2026-03-31
Fidelity Concord Street Trust-Fidelity Series Total Market Index Fundfund0.10%$0.00B+117.86%2026-03-31
EA Series Trust-EA Bridgeway Omni Small-Cap Value ETFfund0.05%$0.00B+0.00%2025-12-31
Invesco Exchange-Traded Fund Trust-Invesco RAFI US 1500 Small-Mid ETFfund0.03%$0.00B-0.05%2026-04-30
Invesco Exch-Trd Fd. TRT II-Invesco NASDAQ Future Gen 200 ETFfund0.03%$0.00B+3.21%2026-04-30
VANGUARD Inst. INDEX Fd.S-Vanguard Inst. Total Stock Market Index Fd.fund0.02%$0.00B+100.00%2025-12-31
TickerCapScoreP/EFwd P/EEV/EBITDAROEGrossD/EDiv
PTGX
Protagonist Therapeutics Inc. Common Stock
$6.6B5------0.00%
CELC
Celcuity Inc. Common Stock
$6.7B5------0.00%
ACLX
Arcellx Inc. Common Stock
$6.7B5-------
KYMR
Kymera Therapeutics Inc. Common Stock
$7.0B-----27.1%0%5.230.00%
TECH
Bio-Techne Corp Common Stock
$7.1B3672.724.4----63.00%
HALO
Halozyme Therapeutics Inc. Common Stock
$7.9B7325.56.6----0.00%
Peers selected by sector + industry + nearest market cap. Best in column highlighted green, worst red.
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Upgrade from $15/mo →
Recent Alerts
No alerts yet for OVID.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →
Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.